MEDICO35.00

Medico Remedies Limited

· Pharma & Health
₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹0.1 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt8.114.718.818.8
Net Debt6.512.215.115.1
Total Debt/Equity0.150.240.250.25
Net Debt/Equity0.120.200.200.20
Total Debt/EBITDA0.620.981.111.11
Net Debt/EBITDA0.500.810.890.86
Interest Coverage (EBIT/Interest)12.1810.337.717.71
Total Debt/Total Capital %13.3219.0919.9719.97
As Filed — company-reported covenants
Debt/Equity (as filed)0.250.01
Debt Service Coverage (as filed)11.160.10
Interest Service Coverage (as filed)20.3519.2211.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.